SCHEMBL7420467

SCHEMBL7420467

CCCCC(NC(=O)c1ccc(OCc2ccc3ccccc3c2)cc1)C(=O)CNS(C)(=O)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.45
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
CA2 P00918 2/20 0.43
ADAMTS4 O75173 1/20 0.42
MMP13 P45452 1/20 0.42
CCKBR P32239 1/20 0.42
ALOX5 P09917 1/20 0.41
PLG P00747 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
DHFR P00374 2/20 0.41
FPGS Q05932 2/20 0.41
PTPN2 P17706 1/20 0.40
CDC25B P30305 1/20 0.40
BCL2 P10415 1/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678439 0.91 ADAMTS4 (0.48) PTPN1NPC1MAPTCA2ADAMTS4
SCHEMBL7702953 0.87 PTPN1 (0.53) PTPN1NPC1MAPTCA2ADAMTS4
SCHEMBL7385051 0.87 PTPN1 (0.46) PTPN1NPC1MAPTCCKBRALOX5
SCHEMBL7664997 0.87 PTPN1 (0.51) PTPN1NPC1MAPTCCKBRALOX5
SCHEMBL7682464 0.85 CA2 (0.42) MAPTCA2MMP13CCKBRDHFR
SCHEMBL7428036 0.83 CA2 (0.45) NPC1CA2MMP13CCKBRHDAC3
SCHEMBL7425669 0.80 ALDH1A1 (0.52) CA2MMP13CCKBRHDAC3HDAC1
SCHEMBL7701695 0.78 CA2 (0.52) PTPN1NPC1MAPTCA2ADAMTS4
SCHEMBL7391842 0.76 HDAC8 (0.46) NPC1CA2CCKBR
SCHEMBL7686484 0.76 CA2 (0.44) CA2CCKBRDHFRFPGSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed
EP-1073632-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-07 EP disclosed
WO-1999054293-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed